Brief: Nextcell Pharma Q4 Operating Loss Widens To SEK 4.9 Mln
30/10/2020 07:29
Oct 30 (Reuters) - NextCell Pharma AB NXTCL.ST :
* Q4 OPERATING INCOME AMOUNTED TO SEK 842 254 (551 708)
* Q4 OPERATING RESULT AMOUNTED TO SEK -4 877 349 (-4 720
587).
Source text for Eikon: ID:nWkr7bPbV2
Further company coverage: NXTCL.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 587785110;))
Recent news on NextCell Pharma AB
See all newsBrief: NextCell Pharma Q1 Operating Income At SEK 2.8 Million
Brief: Nextcell Pharma Q4 Operating Income SEK 1.8 Mln
Brief: Nextcell Pharma Says ProTrans Data Show Insulin Production Preservation
Brief: NextCell Board Proposes Directed Issue Of 15,000,000 Shares
Brief: Nextcell Decides To Propose Directed Share Issue Of SEK 15 Mln